Literature DB >> 11237375

Menstrual and reproductive factors in relation to ovarian cancer risk.

L Titus-Ernstoff1, K Perez, D W Cramer, B L Harlow, J A Baron, E R Greenberg.   

Abstract

We assessed menstrual and reproductive factors in relation to ovarian cancer risk in a large, population-based, case-control study. 563 cases in Massachusetts and New Hampshire were ascertained from hospitals and statewide tumour registries; control women (n = 523) were selected through random digit dialing and matched to case women by age and telephone sampling unit. We used multivariate logistic regression to evaluate factors in relation to risk of ovarian cancer and the major tumour histologic subtypes. Ovarian cancer risk was reduced among parous women, relative to nulliparous women (OR = 0.4; 95% CI = 0.3-0.6). Among parous women, higher parity (P = 0.0006), increased age at first (P = 0.03) or last (P = 0.05) birth, and time since last birth (P = 0.04) were associated with reduced risk. Early pregnancy losses, abortions, and stillbirths were unrelated to risk, but preterm, term, and twin births were protective. Risk was lower among women who had breast-fed, relative to those who had not (OR = 0.7; 95% CI = 0.5-1.0), but the average duration of breast-feeding per child was unrelated to risk (P for trend = 0.21). Age at menarche and age at menopause were unrelated to risk overall, although increasing menarcheal age was protective among premenopausal women (P = 0.02). Menstrual cycle characteristics and symptoms were generally unrelated to risk, although cycle-related insomnia was associated with decreased risk (OR = 0.5; 95% CI = 0.3-0.8). We found no association between the type of sanitary product used during menstruation and ovarian cancer risk. In analyses by histologic subtype, reproductive and menstrual factors had most effect on risk of endometrioid/clear cell tumours, and least influential with regard to risk of mucinous tumours. Overall, our findings offer some support to current hypotheses of ovarian pathogenesis, and show aetiologic differences among the tumour subtypes. Copyright 2001 Cancer Research Campaign.

Entities:  

Mesh:

Year:  2001        PMID: 11237375      PMCID: PMC2363792          DOI: 10.1054/bjoc.2000.1596

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  37 in total

1.  Pooled analysis of 3 European case-control studies of ovarian cancer: II. Age at menarche and at menopause.

Authors:  S Franceschi; C La Vecchia; M Booth; A Tzonou; E Negri; F Parazzini; D Trichopoulos; V Beral
Journal:  Int J Cancer       Date:  1991-08-19       Impact factor: 7.396

2.  A prospective study of reproductive factors and risk of epithelial ovarian cancer.

Authors:  S E Hankinson; G A Colditz; D J Hunter; W C Willett; M J Stampfer; B Rosner; C H Hennekens; F E Speizer
Journal:  Cancer       Date:  1995-07-15       Impact factor: 6.860

3.  Lactation and the risk of epithelial ovarian cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.

Authors:  K A Rosenblatt; D B Thomas
Journal:  Int J Epidemiol       Date:  1993-04       Impact factor: 7.196

4.  Parity, age at first childbirth, and risk of ovarian cancer.

Authors:  H O Adami; C C Hsieh; M Lambe; D Trichopoulos; D Leon; I Persson; A Ekbom; P O Janson
Journal:  Lancet       Date:  1994-11-05       Impact factor: 79.321

5.  Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Survey of Women's Health Study Group.

Authors:  D Purdie; A Green; C Bain; V Siskind; B Ward; N Hacker; M Quinn; G Wright; P Russell; B Susil
Journal:  Int J Cancer       Date:  1995-09-15       Impact factor: 7.396

6.  Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group.

Authors:  A S Whittemore; R Harris; J Itnyre
Journal:  Am J Epidemiol       Date:  1992-11-15       Impact factor: 4.897

7.  Parity, contraception, infertility, and the risk of epithelial ovarian cancer.

Authors:  H A Risch; L D Marrett; G R Howe
Journal:  Am J Epidemiol       Date:  1994-10-01       Impact factor: 4.897

8.  Pooled analysis of 3 European case-control studies: I. Reproductive factors and risk of epithelial ovarian cancer.

Authors:  E Negri; S Franceschi; A Tzonou; M Booth; C La Vecchia; F Parazzini; V Beral; P Boyle; D Trichopoulos
Journal:  Int J Cancer       Date:  1991-08-19       Impact factor: 7.396

9.  Reproductive variables, tobacco, ethanol, coffee and somatometry as risk factors for ovarian cancer.

Authors:  A Polychronopoulou; A Tzonou; C C Hsieh; G Kaprinis; A Rebelakos; N Toupadaki; D Trichopoulos
Journal:  Int J Cancer       Date:  1993-09-30       Impact factor: 7.396

10.  Personal characteristics relating to risk of invasive epithelial ovarian cancer in older women in the United States.

Authors:  A S Whittemore
Journal:  Cancer       Date:  1993-01-15       Impact factor: 6.860

View more
  52 in total

Review 1.  Modern trends into the epidemiology and screening of ovarian cancer. Genetic substrate of the sporadic form.

Authors:  Maria Koutsaki; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2011-12-09       Impact factor: 3.201

2.  Preterm delivery is associated with an increased risk of epithelial ovarian cancer among parous women.

Authors:  Camilla Sköld; Tone Bjørge; Anders Ekbom; Anders Engeland; Mika Gissler; Tom Grotmol; Laura Madanat-Harjuoja; Anne Gulbech Ording; Olof Stephansson; Britton Trabert; Steinar Tretli; Rebecca Troisi; Henrik Toft Sørensen; Ingrid Glimelius
Journal:  Int J Cancer       Date:  2018-07-10       Impact factor: 7.396

Review 3.  Role of p53 and Rb in ovarian cancer.

Authors:  David C Corney; Andrea Flesken-Nikitin; Jinhyang Choi; Alexander Yu Nikitin
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

4.  Hormonal risk factors for ovarian cancer in the Albanian case-control study.

Authors:  Edlira Pajenga; Tefta Rexha; Silva Çeliku; Gazmend Bejtja; Mimoza Pisha
Journal:  Bosn J Basic Med Sci       Date:  2013-05       Impact factor: 3.363

5.  Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population-based case-control study.

Authors:  H R Harris; L J Titus; D W Cramer; K L Terry
Journal:  Int J Cancer       Date:  2016-10-06       Impact factor: 7.396

6.  Reproductive factors and ovarian cancer risk in African-American women.

Authors:  Patricia G Moorman; Anthony J Alberg; Elisa V Bandera; Jill Barnholtz-Sloan; Melissa Bondy; Michele L Cote; Ellen Funkhouser; Edward S Peters; Ann G Schwartz; Paul Terry; Sydnee Crankshaw; Frances Wang; Joellen M Schildkraut
Journal:  Ann Epidemiol       Date:  2016-07-18       Impact factor: 3.797

Review 7.  The immune system in the pathogenesis of ovarian cancer.

Authors:  Bridget Charbonneau; Ellen L Goode; Kimberly R Kalli; Keith L Knutson; Melissa S Derycke
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

8.  Breast-feeding the last born child and risk of ovarian cancer.

Authors:  Linda Titus-Ernstoff; Judy R Rees; Kathryn L Terry; Daniel W Cramer
Journal:  Cancer Causes Control       Date:  2009-11-10       Impact factor: 2.506

9.  Ovarian cancer risk factors in African-American and white women.

Authors:  Patricia G Moorman; Rachel T Palmieri; Lucy Akushevich; Andrew Berchuck; Joellen M Schildkraut
Journal:  Am J Epidemiol       Date:  2009-07-15       Impact factor: 4.897

10.  The utility of web mining for epidemiological research: studying the association between parity and cancer risk.

Authors:  Georgia Tourassi; Hong-Jun Yoon; Songhua Xu; Xuesong Han
Journal:  J Am Med Inform Assoc       Date:  2015-11-27       Impact factor: 4.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.